Results 201 to 210 of about 88,489 (340)

Retracted: The Clinical Efficacy of Cedilanid and Isosorbide Dinitrate plus Pericardial Dissection for Chronic Constrictive Pericarditis in the Elderly and Its Influence on Plasma Endothelin, Atrial Natriuretic Peptide, and Systemic Immune-Inflammation Index. [PDF]

Evid Based Complement Alternat Med, 2023
And Alternative Medicine EC.
europepmc   +1 more source

Differential processing of plasma-ANF in cardiovascular disease [PDF]

, 1987
Arendt, Rainer M., Brenner, Barry M., Gerbes, Alexander L., Ritter, D., Stangl, E.   +4 more
core  

Elevated central venous pressure: A consequence of exercise training-induced hypervolemia [PDF]

Resting plasma volumes, and arterial and central venous pressures (CVP) were measured in 16 men before and after exercise training to determine if training-induced hypervolemia could be explained by a change in total vascular capacitance.
Convertino, Victor A., Mack, Gary W., Nadel, Ethan R.   +2 more
core   +1 more source

Circulating CD19 B cell count, myocardial injury and clinical outcomes in patients with heart failure

ESC Heart Failure, EarlyView.
Circulating CD19 B cell counts negatively correlated with myocardial injury. CD19 B cell count was an independent predictor for all‐cause mortality and HF‐related events, but not other lymphocyte subsets. Circulating CD19 B cell counts correlated to myocardial injury and could be a feasible marker for clinical outcomes in patients with HF.
Yuta Kobayashi, Yoichiro Otaki, Tetsu Watanabe, Ryuhei Yamaguchi, Hiroe Ono, Shingo Tachibana, Junya Sato, Naoaki Hashimoto, Masahiro Wanezaki, Daisuke Kutsuzawa, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

Inhibiting atrial natriuretic peptide clearance reduces myocardial fibrosis and improves cardiac function in diabetic rats. [PDF]

Eur Heart J Open
Bakhos JJ, Saliba Y, Hajal J, Achkouty G, Oskaridjian H, Albuquerque M, Azevedo C, Semaan A, Suffee N, Balse E, Hatem SN, Fares N.   +11 more
europepmc   +1 more source

Pleiotropic Roles of Atrial Natriuretic Peptide in Anti-Inflammation and Anti-Cancer Activity. [PDF]

Cancers (Basel), 2022
Fu H, Zhang J, Cai Q, He Y, Yang D.
europepmc   +1 more source

Age‐adjusted natriuretic peptide thresholds for a diagnosis of heart failure in the community: Diagnostic accuracy study

ESC Heart Failure, EarlyView.
Abstract Background European Society of Cardiology (ESC) chronic heart failure (HF) guidelines recommend a single N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) threshold of ≥125 pg/mL for specialist referral in symptomatic patients; however, natriuretic peptide levels increase with age.
Clare J. Taylor, Kathryn S. Taylor, Nicholas R. Jones, Jose M. Ordóñez‐Mena, Antoni Bayes‐Genis, F.D. Richard Hobbs   +5 more
wiley   +1 more source

Cardiac corin and atrial natriuretic peptide regulate liver glycogen metabolism and glucose homeostasis. [PDF]

Cardiovasc Diabetol
Li W, Zhang X, Zhou Z, Guo W, Wang M, Zhou T, Liu M, Wu Q, Dong N.   +8 more
europepmc   +1 more source

Neuroendocrine hormone status and diuretic response to atrial natriuretic peptide in patients with acute heart failure. [PDF]

ESC Heart Fail, 2022
Matsumoto S, Nakamura N, Konishi M, Shibata A, Kida K, Ishii S, Ikeda T, Ikari Y.   +7 more
europepmc   +1 more source

Genetics, cardiac phenotype and cardiovascular outcomes in Fabry disease patients in Finland

ESC Heart Failure, EarlyView.
Abstract Aims To investigate the genetics, cardiac phenotype and cardiovascular outcomes of Finnish Fabry patients. Methods and results Among the 109 patients with Fabry disease (FD) diagnosed in Finland by 2018, 97 (89%; 32 males and 65 females, mean ages 42 and 52 years) were followed for a mean of 12 years.
Kati Valtola, Päivi Pietilä‐Effati, Jonna M. E. Männistö, Susanne Walls, Ilkka Kantola, Johanna Kuusisto   +5 more
wiley   +1 more source